Article thumbnail

Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer

By Koji Yasuda, Takako Nirei, Eiji Sunami, Hirokazu Nagawa and Joji Kitayama
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1997). al: Activated cytotoxic T cells as prognostic marker in Hodgkin’s disease. Blood
  2. (2003). al: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
  3. (2004). al: Preoperative versus postoperative chemoradiotherapy for rectal cancer.
  4. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol 5:47.
  5. (2007). Crane CH: Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer
  6. (2007). de Vries A: Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis.
  7. (2009). Demaria S: Systemic effects of local radiotherapy. Lancet Oncol
  8. (1979). Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma.
  9. (2001). EG: Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene
  10. (2008). EM: Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity.
  11. (2009). et al: CD3+ cells at the invasive margin of Yasuda et al. Radiation Oncology 2011, 6:49 Page 5 of 6deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Lancet Oncol
  12. (2009). et al: Temporal Patterns of Fatigue Predict Pathologic Response in Patients Treated with Preoperative Chemoradiation Therapy for Rectal Cancer. Int J Radiat Oncol Biol Phys
  13. (2007). et al: Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med
  14. (2007). Formenti SC: Sensors of ionizing radiation effects on the immunological microenvironment of cancer.
  15. (2009). HL: Biomarkers for response to neoadjuvant chemoradiation for rectal cancer.
  16. (2005). Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer
  17. (2009). Japanese Classification of Colorectal Carcinoma.
  18. (2006). JP: Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. Dis Colon Rectum
  19. (2002). Meijer CJ: High numbers of granzyme B/ CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent.
  20. (2009). Meropol NJ: Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
  21. (2006). Niedobitek G: Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res
  22. (2009). Okayasu I: High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction.
  23. (2006). Ollier JC: Chemotherapy with preoperative radiotherapy in rectal cancer.
  24. (2008). Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.
  25. (2006). Schmitz-Winnenthal FH, et al: Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg
  26. (2008). Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy. Clin Cancer Res
  27. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science
  28. (2008). Xu ZF: Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma. Zhonghua Zhong Liu Za Zhi